AN2 Therapeutics, Inc. Common Stock (ANTX)
AN2 Therapeutics, Inc. Common Stock (ANTX) has a 16-report earnings history dating back to May 10, 2022. Its average absolute post-earnings move is ±9.21%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +64.54% (Aug 11, 2022) and its largest decline was -9.32% (May 11, 2026). The next earnings report is predicted for 2026-11-12 (estimated).
Earnings reactions
How ANTX moved on each past earnings report.
Earnings Impact
Total Earnings
16
Avg Abs. Movement
±9.21%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 11, 2026 | ☽ POST | +6.53% | open_in_new |
| May 11, 2026 | ☽ POST | -9.32% | open_in_new |
| Mar 17, 2026 | ☽ POST | -7.69% | open_in_new |
| Nov 12, 2025 | ☽ POST | +0% | open_in_new |
Earnings Count
16
Total earnings in dataset
Avg Abs. Movement
±9.21%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20261013 | open_in_new SEC.gov |
| 4 | 20261013 | open_in_new SEC.gov |
| 4 | 20261013 | open_in_new SEC.gov |
| 4 | 20260916 | open_in_new SEC.gov |
| S-8 | 20260914 | open_in_new SEC.gov |
| 4 | 20260911 | open_in_new SEC.gov |
| 4 | 20260908 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 4 | 20260902 | open_in_new SEC.gov |
| 3 | 20260827 | open_in_new SEC.gov |
Frequently asked about ANTX earnings
When does AN2 Therapeutics, Inc. Common Stock report earnings next? expand_more
AN2 Therapeutics, Inc. Common Stock (ANTX)'s next earnings date is estimated for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ANTX stock move after earnings? expand_more
Over 16 reports, ANTX has moved an average of ±9.21% the session after earnings, closing higher 50.0% of the time.
What was ANTX's biggest post-earnings move? expand_more
ANTX's largest post-earnings gain on record was +64.54% on Aug 11, 2022, and its largest decline was -9.32% on May 11, 2026.
Where can I find AN2 Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of AN2 Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- American Healthcare REIT, Inc. (AHR) earnings 2026-11-09
- ALICO, INC. (ALCO) earnings 2026-11-09
- Arbutus Biopharma Corp (ABUS) earnings 2026-11-09
- Abacus Global Management, Inc. (ABX) earnings 2026-11-09
- ACCESS Newswire Inc. (ACCS) earnings 2026-11-09
- Aprea Therapeutics, Inc. Common stock (APRE) earnings 2026-11-09
- Aptevo Therapeutics Inc. Common Stock (APVO) earnings 2026-11-09
- Zumiez Inc (ZUMZ) earnings 2026-11-09